The Impact of Novel Anticoagulants on Thrombophilia Assays


About this study

The purpose of this study is to determine the extent that new blood thinners interfere with blood testing for clotting disorders. This research is to better understand the extent of which these new blood thinners interfere with our blood clotting tests.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients with a clinical indication for novel anticoagulant initiation.

Exclusion Criteria: 

  • Current anticoagulation therapy with either a novel or traditional anticoagulant.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Robert McBane, M.D.

Contact us for the latest status

Contact information:

Robert McBane M.D.

(507) 266-3964

More information


Publications are currently not available

Mayo Clinic Footer